What to Expect


12:00 PM: Introduction to Roche - Led by Nadia Haque

12:10 PM: How the Roche Golden Ticket got Kano Therapeutics off the Ground - Floris Engelhardt, CEO

12:20 PM: Platform & Partnerships Building Fireside Chat - Joel Barrish & Barbara Lueckel

12:45 PM: Golden Ticket Winner Announced - Barbara Lueckel

1:00 PM: Networking


Cerberus Therapeutics is pioneering an alpaca-derived single domain antibody fragment (VHH)-based platform to create novel therapeutics capable of immune modulation.

Form Biologics is developing a new platform technology for high concentration injectable formulations of biologics therapeutics.

Transcera is a preclinical biotech company harnessing the biology of sphingolipids to unlock the potential of biologic medicines. 

Featured Speakers

Nadia Haque
Executive Director
Roche Pharma Partnering 

Floris Engelhardt
Co-Founder & CEO
Kano Therapeutics

Joel Barrish
Venture Partner
RA Capital Ventures

Barbara Lueckel
Global Head Research Technology
Roche Pharma Partnering